Skip to content
Search

Latest Stories

Alastair Buxton outlines vision for Community Pharmacy at Westminster Health Forum

Alastair Buxton outlines vision for Community Pharmacy at Westminster Health Forum
Alastair Buxton, Director of NHS Services at CPE, outlines critical issues and solutions at the Westminster Health Forum, urging sustainable support amidst sector struggles

In a stirring address at the recent conference on Pharmacy at the Westminster Health Forum, Director of NHS Services at Community Pharmacy England (CPE), Alastair Buxton presented a stark assessment of the community pharmacy sector's challenges.

Highlighting years of financial constraints imposed by the NHS and government, Buxton warned of a sector teetering on the edge of survival.


"There have been no years of financial and operational squeezes applied by the NHS and

government to the community pharmacy sector, so as a consequence, there are a lot of pharmacies that are on the on the brink of survival -battling for survival," he said.

Buxton underscored the critical and indispensable role of community pharmacies in delivering essential NHS services, from dispensing medications to innovative initiatives like the Discharge Medicine Service and Contraception Service.

Despite these, he lamented that many pharmacies are struggling to stay afloat amidst stagnant funding and escalating demands exacerbated by the pandemic.

Buxton detailed alarming statistics, revealing approximately ten pharmacy closures per week and a meager 5 per cent reporting profitability.

Attributing these closures to an overwhelming surge in demand for services and lack of workforce, Buxton pointed that pharmacists migrate to other healthcare sectors offering better remuneration.

Vision for community pharmacists

Yet amidst these challenges, Buxton remained resolute about the future of community pharmacies.

He outlined a collaborative initiative with the Nuffield Trust and the King's Fund to chart a path forward, emphasising preventive care, clinical services, and seamless integration into primary care.

This vision emphasises four key themes: preventing ill health, providing clinical care, supporting long-term condition management, and integrating pharmacy services into primary care.

"We commissioned this work to develop a vision that has input from a wide range of stakeholders, including pharmacy organisations, the NHS, and patient groups," Buxton said.

He stressed the importance of using the clinical skills within the pharmacy workforce and ensuring that pharmacies remain open and accessible.

Buxton also highlighted the significant role community pharmacies could play in public health initiatives and advocated for expanded vaccination services, substance use services, and weight management programs, aligning with NHS England's vaccination strategy.

"A smoking or nicotine cessation service would offer significant health and economic benefits," he added, pointing out that such services could prevent long-term health issues and reduce healthcare costs.

The integration of independent prescribing into community pharmacy was another critical aspect of Buxton's vision.

He noted that by 2026, all newly qualified pharmacists would be independent prescribers, significantly expanding the scope of services that pharmacies can offer.

"This will be a radical step change in how we use the skills of pharmacists," he said, advocating for collaboration with general practice to manage long-term conditions.

Buxton concluded his session by emphasising the need for a shared vision with the government and the NHS and called for a commitment to sustainable funding to support the ambitious plans for community pharmacy

"We can't build on services if pharmacies are not open," Buxton emphasised, rallying for sustainable funding and greater recognition of the clinical skills within pharmacy teams.

Buxton urged the government and NHS to forge a unified vision for community pharmacy, one that secures adequate funding to safeguard these vital healthcare providers.

The Westminster Health Forum policy conference brought together key stakeholders to discuss the future of pharmacy in England's healthcare landscape.

Addressing critical issues such as funding sustainability, digital innovation, and regulatory developments, speakers highlighted the vital role of community pharmacies in meeting escalating healthcare demands.

More For You

ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
​The next generation of BD Rowa Smart launched

The latest BD Rowa™ Smart introduces a more intuitive user interface.

Photo credit: BD Rowa

BD Rowa unveils next-generation smart dispensing robot with sustainable design

Leading medical technology company BD Rowa has announced the launch of the next generation of its smart dispensing robot, offering enhanced convenience with a sustainable design.

Currently in its final development phase, the latest BD Rowa™ Smart introduces a more intuitive user interface designed to streamline operations and enhance the user experience.

Keep ReadingShow less
Independent Prescribing: Government aims to complete pathfinder programme evaluation by autumn 2025

Pharmacist prescribers at 210 ‘pathfinder’ sites were allowed to trial prescribing models within integrated primary care services.

Photo credit: gettyimages

Independent prescribing: Pathfinder programme evaluation to be completed by autumn, says Kinnock

Health minister Stephen Kinnock has revealed that the evaluation of the Community Pharmacy Independent Prescribing Pathfinder Programme could be completed by Autumn 2025.

Kinnock was responding to a question from James Naish, Labour MP for Rushcliffe, who asked what steps the minister was taking to ensure continued support for the Pathfinder Programme and independent prescribing to maximise direct prescribing capacity in England.

Keep ReadingShow less